Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Frequently Asked Questions Q1: What is GHK-Cu and why does it decline with age
Scafidi S, Fiskum G, Lindauer SL, et al
While many peptide therapies are traditionally administered by medical providers via injection, newer delivery systems are making these buzzy compounds more accessible than ever
We therefore suggest using the term lipid-driven eryptosis when sphingolipid-derived metabolites are involved
When the water-soluble composition of the invention is converted into an aqueous solution for administration, the concentration of the pharmacologically active peptide salt in said solution should preferably be about 0.0000001 to 10 % (w/v), more preferably about 0.000001 to 5% (w/v) or most preferably about 0.00001 to 1% (w/v)
Selected References (PubMed/PMC) Pickart et al
US$ 22.75
US$ 26.42
US$ 23.81
US$ 26.04
US$ 24.12
US$ 21.41
US$ 25.93
